Sanofi, Dynavax expect US waiting period to expire Jan. 30; deal filed in Germany
Sanofi and Dynavax Technologies said they expect the antitrust waiting period with the US antitrust authorities for their $2.2 billion deal to expire on Jan. 30. The pharmaceutical companies also said...To view the full article, register now.
Already a subscriber? Click here to view full article